Balchem Corporation
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.04B | $953.7M | $922.4M | $942.4M | $799.0M | $703.6M | $643.7M |
| Cost of Revenue | — | $666.5M | $617.5M | $620.4M | $661.9M | $555.8M | $479.7M | $432.3M |
| Gross Profit | — | $370.6M | $336.2M | $302.1M | $280.5M | $243.2M | $223.9M | $211.4M |
| Gross Margin | — | 35.7% | 35.3% | 32.7% | 29.8% | 30.4% | 31.8% | 32.8% |
| Operating Expenses | ||||||||
| Research & Development | — | $18.5M | $16.8M | $15.0M | $12.2M | $13.5M | $10.3M | $11.4M |
| SG&A Expense | — | $67.4M | $67.6M | $53.4M | $55.7M | $41.7M | $43.8M | $36.5M |
| Operating Income | — | $209.3M | $182.9M | $159.2M | $145.2M | $127.5M | $111.1M | $102.6M |
| Operating Margin | — | 20.2% | 19.2% | 17.3% | 15.4% | 16.0% | 15.8% | 15.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $199.0M | $166.5M | $137.3M | $133.7M | $125.2M | $106.4M | $96.5M |
| Income Tax Expense | — | $44.2M | $38.0M | $28.7M | $28.4M | $29.1M | $21.8M | $16.8M |
| Net Income | — | $154.8M | $128.5M | $108.5M | $105.4M | $96.1M | $84.6M | $79.7M |
| Net Margin | — | 14.9% | 13.5% | 11.8% | 11.2% | 12.0% | 12.0% | 12.4% |
| EPS (Basic) | — | $4.80 | $3.97 | $3.38 | $3.29 | $2.98 | $2.63 | $2.48 |
| EPS (Diluted) | — | $4.75 | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 | $2.45 |
| Shares Outstanding (Basic) | 32.0M | 32.3M | 32.3M | 32.1M | 32.0M | 32.2M | 32.2M | 32.1M |
| Shares Outstanding (Diluted) | 32.0M | 32.6M | 32.7M | 32.4M | 32.4M | 32.7M | 32.5M | 32.5M |
| Dividends Per Share | — | $0.96 | $0.87 | $0.79 | $0.71 | — | — | — |